Please assess the completion status of the following clinical trial:

Trial Title: Premedication With Nebulized Ketamine,Dexmedetomidine Versus Midazolam in Oncologic Preschool Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* physical status I and II, scheduled for bone marrow aspirate and biopsy~Exclusion Criteria:~* known allergy to the studied drugs,~* organ dysfunction,~* cardiac dysrrhythmia and/or congenital heart disease,~* psychotropic medication use and mental retardation

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 7 Years
- Healthy Volunteers: f

Study Arms:
- nebulized ketamine (Type: ACTIVE_COMPARATOR): patients will be premedicated with nebulized ketamine solution (2 mg/kg)
- nebulized dexmedetomidine (Type: ACTIVE_COMPARATOR): patients will be premedicated with nebulized dexmedetomidine solution (2 μg/kg)
- nebulized midazolam (Type: ACTIVE_COMPARATOR): patients will be premedicated with midazolam (0.2 mg/kg) nebulized solution

Based on this trial design, predict the completion outcome and termination type (if applicable).